LEXINGTON, Mass., April 30, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Deutsche Bank Securities 37th Annual Health Care Conference at 10:00 a.m. ET on May 7, 2012, in Boston.
